Perioperative serum albumin as a predictor of adverse outcomes in abdominal surgery: prospective cohort hospital based study in Northern Tanzania.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
14 Jul 2020
Historique:
received: 18 04 2020
accepted: 08 07 2020
entrez: 16 7 2020
pubmed: 16 7 2020
medline: 19 12 2020
Statut: epublish

Résumé

Albumin is an important protein that transports hormones, fatty acids, and exogenous drugs; it also maintains plasma oncotic pressure. Albumin is considered a negative active phase protein because it decreases during injuries and sepsis. In spite of other factors predicting surgical outcomes, the effect of pre and postoperative serum albumin to surgical complications can be assessed by calculating the percentage decrease in albumin (delta albumin). This study aimed to explore perioperative serum albumin as a predictor of adverse outcomes in major abdominal surgeries. All eligible adult participants from Kilimanjaro Christian Medical Centre Surgical Department were enrolled in a convenient manner. Data were collected using a study questionnaire. Full Blood Count (FBP), serum albumin levels preoperatively and on postoperative day 1 were measured in accordance with Laboratory Standard Operating Procedures (SOP). Data was entered and analyzed using STATA version 14. Association and extent of decrease in albumin levels as a predictor of surgical site infection (SSI), delayed wound healing and death within 30 days of surgery was determined using ordinal logistic regression models. In determining the diagnostic accuracy, a Non-parametric Receiver Operating Curve (ROC) model was used. We adjusted for ASA classification, which had a negative confounding effect on the predictive power of the percent drop in albumin to adverse outcomes. Sixty one participants were studied; the mean age was 51.6 (SD16.3), the majorities were males 40 (65.6%) and post-operative adverse outcomes were experienced by 28 (45.9%) participants. In preoperative serum albumin values, 40 (67.8%) had lower than 3.4 g/l while 51 (91%) had postoperative albumin values lower than 3.4 g/l. Only 15 (27.3%) had high delta albumin with the median percentage value of 14.77%. Delta albumin was an independent significant factor associated with adverse outcome (OR: 6.68; 95% CI: 1.59, 28.09); with a good predictive power and area under ROC curve (AUC) of 0.72 (95% CI 0.55 0.89). The best cutoff value was 11.61% with a sensitivity of 76.92% and specificity of 51.72%. Early perioperative decreases in serum albumin levels may be a good, simple and cost effective tool to predict adverse outcomes in major abdominal surgeries.

Sections du résumé

BACKGROUND BACKGROUND
Albumin is an important protein that transports hormones, fatty acids, and exogenous drugs; it also maintains plasma oncotic pressure. Albumin is considered a negative active phase protein because it decreases during injuries and sepsis. In spite of other factors predicting surgical outcomes, the effect of pre and postoperative serum albumin to surgical complications can be assessed by calculating the percentage decrease in albumin (delta albumin). This study aimed to explore perioperative serum albumin as a predictor of adverse outcomes in major abdominal surgeries.
METHODS METHODS
All eligible adult participants from Kilimanjaro Christian Medical Centre Surgical Department were enrolled in a convenient manner. Data were collected using a study questionnaire. Full Blood Count (FBP), serum albumin levels preoperatively and on postoperative day 1 were measured in accordance with Laboratory Standard Operating Procedures (SOP). Data was entered and analyzed using STATA version 14. Association and extent of decrease in albumin levels as a predictor of surgical site infection (SSI), delayed wound healing and death within 30 days of surgery was determined using ordinal logistic regression models. In determining the diagnostic accuracy, a Non-parametric Receiver Operating Curve (ROC) model was used. We adjusted for ASA classification, which had a negative confounding effect on the predictive power of the percent drop in albumin to adverse outcomes.
RESULTS RESULTS
Sixty one participants were studied; the mean age was 51.6 (SD16.3), the majorities were males 40 (65.6%) and post-operative adverse outcomes were experienced by 28 (45.9%) participants. In preoperative serum albumin values, 40 (67.8%) had lower than 3.4 g/l while 51 (91%) had postoperative albumin values lower than 3.4 g/l. Only 15 (27.3%) had high delta albumin with the median percentage value of 14.77%. Delta albumin was an independent significant factor associated with adverse outcome (OR: 6.68; 95% CI: 1.59, 28.09); with a good predictive power and area under ROC curve (AUC) of 0.72 (95% CI 0.55 0.89). The best cutoff value was 11.61% with a sensitivity of 76.92% and specificity of 51.72%.
CONCLUSION CONCLUSIONS
Early perioperative decreases in serum albumin levels may be a good, simple and cost effective tool to predict adverse outcomes in major abdominal surgeries.

Identifiants

pubmed: 32664910
doi: 10.1186/s12893-020-00820-w
pii: 10.1186/s12893-020-00820-w
pmc: PMC7362485
doi:

Substances chimiques

Serum Albumin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155

Références

World J Gastroenterol. 2008 Feb 28;14(8):1248-51
pubmed: 18300352
World J Gastroenterol. 2017 Jul 21;23(27):4978-4985
pubmed: 28785152
Int J Colorectal Dis. 2017 Oct;32(10):1439-1446
pubmed: 28823064
Dis Colon Rectum. 2017 Mar;60(3):326-334
pubmed: 28177996
PLoS One. 2018 Nov 13;13(11):e0206911
pubmed: 30422980
BMJ Open. 2017 Apr 8;7(4):e013966
pubmed: 28391235
Gastroenterol Res Pract. 2016;2016:8743187
pubmed: 26880899
Asia Pac J Clin Nutr. 2007;16(2):213-7
pubmed: 17468075

Auteurs

Christian Ephata Issangya (CE)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania. christianissangya@gmail.com.
Department of General Surgery, Kilimanjaro Christian Medical Centre, P.O Box 3010, Moshi, Tanzania. christianissangya@gmail.com.

David Msuya (D)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania.
Department of General Surgery, Kilimanjaro Christian Medical Centre, P.O Box 3010, Moshi, Tanzania.

Kondo Chilonga (K)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania.
Department of General Surgery, Kilimanjaro Christian Medical Centre, P.O Box 3010, Moshi, Tanzania.

Ayesiga Herman (A)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania.
Department of General Surgery, Kilimanjaro Christian Medical Centre, P.O Box 3010, Moshi, Tanzania.

Elichilia Shao (E)

Department of General Surgery, Kilimanjaro Christian Medical Centre, P.O Box 3010, Moshi, Tanzania.

Febronia Shirima (F)

Department of General Surgery, Kilimanjaro Christian Medical Centre, P.O Box 3010, Moshi, Tanzania.

Elifaraja Naman (E)

Department of General Surgery, Kilimanjaro Christian Medical Centre, P.O Box 3010, Moshi, Tanzania.

Henry Mkumbi (H)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania.

Jeremia Pyuza (J)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania.
Department of Medical Laboratory, Kilimanjaro Christian Medical Centre, P.O Box 3010, Moshi, Tanzania.

Emmanuel Mtui (E)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania.

Leah Anku Sanga (LA)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania.

Seif Abdul (S)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania.

Beatrice John Leyaro (BJ)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania.

Samuel Chugulu (S)

Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania.
Department of General Surgery, Kilimanjaro Christian Medical Centre, P.O Box 3010, Moshi, Tanzania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH